Alnylam Pharmaceuticals, Inc. SEC filings ALNY

Alnylam Pharmaceuticals, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Sep 12, 2014. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.

Alnylam Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change, Other events
Nov 5, 2026 Nov 2, 2026
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 30, 2026 Jul 30, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 27, 2026 May 20, 2026
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 30, 2026 Apr 30, 2026
ARS Annual report to shareholders Apr 6, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 6, 2026 —
DEF 14A Proxy statement Apr 6, 2026 May 20, 2026
8-K Current report
Officer or director change
Mar 4, 2026 Mar 2, 2026
S-8 Employee stock plan registration Feb 12, 2026 —
10-K Annual report Feb 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 12, 2026 Feb 12, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 11, 2026
8-K Current report
Other events
Dec 11, 2025 Dec 10, 2025
8-K Current report
Officer or director change
Dec 3, 2025 Dec 2, 2025
10-Q Quarterly report Oct 30, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 30, 2025 Oct 30, 2025
8-K Current report
Material agreement, New debt
Oct 3, 2025 Sep 30, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Sep 12, 2025 Sep 12, 2025
8-K Current report
Other events
Sep 10, 2025 Sep 8, 2025
10-Q Quarterly report Jul 31, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 31, 2025 Jul 31, 2025
8-K Current report
Officer or director change
Jun 18, 2025 Jun 12, 2025
UPLOAD Letter from the SEC Jun 17, 2025 —
CORRESP Letter to the SEC May 22, 2025 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 13, 2025 May 8, 2025
UPLOAD Letter from the SEC May 9, 2025 —
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report May 1, 2025 May 1, 2025
DEFA14A Additional proxy material Apr 4, 2025 —
ARS Annual report to shareholders Mar 24, 2025 Dec 31, 2024
DEFA14A Additional proxy material Mar 24, 2025 —
DEF 14A Proxy statement Mar 24, 2025 May 8, 2025
8-K Current report
Other events
Mar 21, 2025 Mar 20, 2025
PRE 14A Preliminary proxy statement Mar 14, 2025 May 8, 2025
8-K Current report
Officer or director change
Mar 5, 2025 Mar 3, 2025
10-K Annual report Feb 13, 2025 Dec 31, 2024
8-K Current report Feb 13, 2025 Feb 13, 2025
8-K Current report
Results of operations
Jan 13, 2025 Jan 12, 2025
10-Q Quarterly report Oct 31, 2024 Sep 30, 2024
8-K Current report Oct 31, 2024 Oct 31, 2024
UPLOAD Letter from the SEC Sep 25, 2024 —
CORRESP Letter to the SEC Aug 22, 2024 —
UPLOAD Letter from the SEC Aug 12, 2024 —
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report Aug 1, 2024 Aug 1, 2024
8-K Current report
Shareholder vote results
May 20, 2024 May 16, 2024
10-Q Quarterly report May 2, 2024 Mar 31, 2024
8-K Current report May 2, 2024 May 2, 2024
ARS Annual report to shareholders Apr 1, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 1, 2024 —
DEF 14A Proxy statement Apr 1, 2024 May 16, 2024
8-K Current report
Officer or director change
Mar 4, 2024 Mar 4, 2024
10-K Annual report Feb 15, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 15, 2024 Feb 15, 2024
8-K Current report
Officer or director change
Jan 19, 2024 Jan 12, 2024
8-K Current report
Results of operations
Jan 8, 2024 Jan 7, 2024
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
8-K Current report
Other events
Oct 10, 2023 Oct 9, 2023
8-K Current report
Officer or director change
Sep 28, 2023 Sep 26, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Results of operations, Officer or director change
Aug 3, 2023 Jul 31, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Jul 26, 2023 Jul 21, 2023
8-K Current report
Other events
Jun 30, 2023 Jun 30, 2023
8-K Current report
Shareholder vote results
May 23, 2023 May 18, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
ARS Annual report to shareholders Apr 3, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 3, 2023 —
DEF 14A Proxy statement Apr 3, 2023 —
8-K Current report
Officer or director change
Mar 8, 2023 Mar 7, 2023
S-8 Employee stock plan registration Feb 23, 2023 —
10-K Annual report Feb 23, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 23, 2023 Feb 23, 2023
CT ORDER Filing Feb 14, 2023 —
8-K Current report
Results of operations
Jan 9, 2023 Jan 8, 2023
8-K Current report
Officer or director change, Other events
Jan 6, 2023 Jan 5, 2023
10-Q Quarterly report Oct 27, 2022 Sep 30, 2022
8-K Current report
Results of operations
Oct 27, 2022 Oct 27, 2022
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
Sep 16, 2022 Sep 12, 2022
8-K Current report
Other events
Sep 13, 2022 Sep 12, 2022
8-K Current report
Officer or director change
Aug 24, 2022 Aug 19, 2022
10-Q Quarterly report Jul 28, 2022 Jun 30, 2022
8-K Current report
Results of operations
Jul 28, 2022 Jul 28, 2022
8-K Current report
Other events
Jun 14, 2022 Jun 13, 2022
8-K Current report
Shareholder vote results
May 23, 2022 May 18, 2022
10-Q Quarterly report Apr 28, 2022 Mar 31, 2022
8-K Current report
Results of operations
Apr 28, 2022 Apr 28, 2022
DEFA14A Additional proxy material Apr 5, 2022 —
DEF 14A Proxy statement Apr 5, 2022 May 18, 2022
8-K Current report
Officer or director change
Apr 5, 2022 Mar 31, 2022
8-K Current report
Other events
Apr 4, 2022 Apr 4, 2022
8-K Current report
Other events
Mar 17, 2022 Mar 17, 2022
10-K Annual report Feb 10, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 10, 2022 Feb 10, 2022
8-K Current report
Results of operations
Jan 10, 2022 Jan 9, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 4, 2022 Jan 4, 2022
8-K Current report
Officer or director change
Dec 20, 2021 Dec 14, 2021
10-Q Quarterly report Oct 28, 2021 Sep 30, 2021
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Oct 28, 2021 Oct 26, 2021
8-K Current report
Officer or director change
Sep 8, 2021 Sep 6, 2021
10-Q Quarterly report Aug 3, 2021 Jun 30, 2021
8-K Current report
Results of operations, Officer or director change, Other events
Aug 3, 2021 Aug 2, 2021
8-K Current report
Shareholder vote results
May 21, 2021 May 18, 2021
10-Q Quarterly report Apr 29, 2021 Mar 31, 2021
8-K Current report
Results of operations
Apr 29, 2021 Apr 29, 2021
8-K Current report
Other events
Apr 12, 2021 Apr 12, 2021
DEFA14A Additional proxy material Apr 2, 2021 —
DEF 14A Proxy statement Apr 2, 2021 May 18, 2021
SEC STAFF LETTER Filing Mar 18, 2021 —
SEC STAFF LETTER Filing Feb 18, 2021 —
S-8 Employee stock plan registration Feb 11, 2021 —
10-K Annual report Feb 11, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 11, 2021 Feb 11, 2021
8-K Current report
Results of operations
Jan 11, 2021 Jan 10, 2021
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Material agreement, Officer or director change
Oct 2, 2020 Sep 30, 2020
8-K Current report
Material agreement
Aug 20, 2020 Aug 15, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Aug 6, 2020 Aug 3, 2020
S-3ASR Automatic shelf registration Jun 5, 2020 —
8-K Current report
Shareholder vote results
May 11, 2020 May 6, 2020
10-Q Quarterly report May 6, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 6, 2020 May 6, 2020
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Apr 13, 2020 Apr 10, 2020
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Apr 6, 2020 Apr 3, 2020
DEFA14A Additional proxy material Mar 24, 2020 —
DEF 14A Proxy statement Mar 23, 2020 May 6, 2020
8-K Current report
Officer or director change
Feb 27, 2020 Feb 26, 2020
S-8 Employee stock plan registration Feb 13, 2020 —
10-K Annual report Feb 13, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 6, 2020 Feb 6, 2020
8-K Current report
Results of operations
Jan 13, 2020 Jan 12, 2020
8-K Current report
Other events
Nov 20, 2019 Nov 20, 2019
10-Q Quarterly report Oct 31, 2019 Sep 30, 2019
8-K Current report
Results of operations
Oct 31, 2019 Oct 31, 2019
8-K Current report
Other events
Oct 3, 2019 Sep 27, 2019
10-Q Quarterly report Aug 6, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 6, 2019 Aug 6, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 11, 2019 Jul 8, 2019
CT ORDER Filing Jul 5, 2019 —
8-K Current report
Other events
May 21, 2019 May 21, 2019
CT ORDER Filing May 2, 2019 —
10-Q Quarterly report May 2, 2019 Mar 31, 2019
CT ORDER Filing May 2, 2019 —
CT ORDER Filing May 2, 2019 —
8-K Current report
Results of operations
May 1, 2019 May 1, 2019
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Apr 26, 2019 Apr 25, 2019
DEFA14A Additional proxy material Apr 10, 2019 —
CT ORDER Filing Apr 10, 2019 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Apr 9, 2019 Apr 8, 2019
DEFA14A Additional proxy material Apr 8, 2019 —
UPLOAD Letter from the SEC Mar 21, 2019 —
DEF 14A Proxy statement Mar 21, 2019 Apr 25, 2019
PRER14A Filing Mar 18, 2019 —
PRE 14A Preliminary proxy statement Mar 11, 2019 Apr 25, 2019
10-K Annual report Feb 14, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 7, 2019 Feb 7, 2019
8-K Current report
Material agreement, Other events
Jan 15, 2019 Jan 14, 2019
424B5 Prospectus supplement Jan 15, 2019 —
424B5 Prospectus supplement Jan 14, 2019 —
8-K Current report
Results of operations
Jan 7, 2019 Jan 7, 2019
8-K Current report
Other events
Dec 10, 2018 Dec 9, 2018
10-Q Quarterly report Nov 7, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 7, 2018 Nov 7, 2018
8-K Current report
Officer or director change
Oct 10, 2018 Oct 9, 2018
8-K Current report
Material agreement
Oct 2, 2018 Sep 27, 2018
CT ORDER Filing Sep 12, 2018 —
8-K Current report
Material agreement
Aug 17, 2018 Aug 14, 2018
8-K Current report
Other events
Aug 10, 2018 Aug 10, 2018
S-8 POS Filing Aug 2, 2018 —
S-8 POS Filing Aug 2, 2018 —
S-8 POS Filing Aug 2, 2018 —
S-8 POS Filing Aug 2, 2018 —
S-8 Employee stock plan registration Aug 2, 2018 —
10-Q Quarterly report Aug 2, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 2, 2018 Aug 2, 2018
CT ORDER Filing Jun 5, 2018 —
8-K Current report
Officer or director change, Shareholder vote results
May 15, 2018 May 10, 2018
10-Q Quarterly report May 4, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 3, 2018 May 3, 2018
8-K Current report
Other events
Apr 20, 2018 Apr 18, 2018
8-K Current report
Material agreement
Apr 3, 2018 Mar 28, 2018
DEF 14A Proxy statement Mar 23, 2018 May 10, 2018
8-K Current report
Officer or director change, Bylaw or fiscal year change
Mar 14, 2018 Mar 8, 2018
10-K Annual report Feb 15, 2018 Dec 31, 2017
8-K Current report
Results of operations
Feb 8, 2018 Feb 8, 2018
CT ORDER Filing Jan 24, 2018 —
CT ORDER Filing Jan 24, 2018 —
UPLOAD Letter from the SEC Jan 23, 2018 —
CORRESP Letter to the SEC Jan 19, 2018 —
UPLOAD Letter from the SEC Jan 10, 2018 —
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
Jan 8, 2018 Jan 6, 2018
8-K Current report
Other events
Jan 3, 2018 Dec 27, 2017
CORRESP Letter to the SEC Dec 11, 2017 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ALNY (Nasdaq)
Fiscal year ends
December 31
Headquarters
Cambridge, MA
SEC filer status
Large accelerated filer
SEC CIK
1178670
Former names
ALNYLAM PHARMACEUTICALS INC (until Jul 2, 2004)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.